GW Pharmaceuticals

Latest stories

7d
FOX Business
Can Marijuana Stocks Succeed Without Federal Legalization?stocks should be avoided: the handful of companies working on marijuana-based m
Can Marijuana Stocks Succeed Without Federal Legalization?
FOX Business / Posted 7 days ago
stocks should be avoided: the handful of companies working on marijuana-based medicines, headlined by the British biopharma GW Pharmaceuticals (NASDAQ: GWPH). After all, GW recently reported positive late-stage results for itsmarijuana-derived... Read more
7d
FOX Business
Can Marijuana Stocks Succeed Without Federal Legalization?stocks should be avoided: the handful of companies working on marijuana-based m
Can Marijuana Stocks Succeed Without Federal Legalization?
FOX Business / Posted 7 days ago
stocks should be avoided: the handful of companies working on marijuana-based medicines, headlined by the British biopharma GW Pharmaceuticals (NASDAQ: GWPH). After all, GW recently reported positive late-stage results for itsmarijuana-derived... Read more
9d
TheStreet.com
Making the right budding investment: Medical versus recreational cannabis companiesStack Up Only a handful of cannabis companies are listed on the Nasdaq, limiti
Making the right budding investment: Medical versus recreational cannabis companies
TheStreet.com / Posted 9 days ago
Stack Up Only a handful of cannabis companies are listed on the Nasdaq, limiting options for investors. These include GW Pharmaceuticals (GWPH) , a U.K.–based biotech company with a cannabis-based epilepsy drug; Insys Therapeutics (INSY - Get... Read more
10d
Channel NewsAsia
GW Pharma's cannabis drug gets orphan drug statusREUTERS: The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuti
GW Pharma's cannabis drug gets orphan drug status
Channel NewsAsia / Posted 10 days ago
REUTERS: The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease. GW said on Thursday that its... Read more
10d
The Lumberjack
The CBD Storyfor everything from anti-inflammatories and anti-convulsants to therapeutic lot
The CBD Story
The Lumberjack / Posted 10 days ago
for everything from anti-inflammatories and anti-convulsants to therapeutic lotions and chapsticks. A UK-based company, GW Pharmaceuticals, produces a high-CBD tincture spray called Epidiolex, which was just classified as an orphan drug by the... Read more
10d
San Antonio Express-News
4 Impressive Marijuana Accomplishments Over the Past 20 Yearsmedical benefits from marijuana, even if the federal government still lists the
4 Impressive Marijuana Accomplishments Over the Past 20 Years
San Antonio Express-News / Posted 10 days ago
medical benefits from marijuana, even if the federal government still lists the substance as illicit. Image source: GW Pharmaceuticals. For example, GW Pharmaceuticals has launched Sativex, an oromucosal spray derived from two cannabinoids... Read more
11d
TheStreet.com
How to invest in Nasdaq-traded marijuana stocks and private pot companiesCannabis Companies The current options for investors are limited to a handful
How to invest in Nasdaq-traded marijuana stocks and private pot companies
TheStreet.com / Posted 11 days ago
Cannabis Companies The current options for investors are limited to a handful of companies listed on the Nasdaq, including GW Pharmaceuticals (GWPH) , a U.K.–based biotech company with a cannabis-based epilepsy drug; Insys Therapeutics (INSY - Get... Read more
13d
CTV News
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
CTV News / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
Denver Post
Cannabis-based epilepsy drug starts debatewhich he said is effective, consistent and doesn't get users high. About two y
Cannabis-based epilepsy drug starts debate
Denver Post / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
WBNS-10TV Columbus
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
WBNS-10TV Columbus / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
The Wilmington Star-News
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
The Wilmington Star-News / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
Spartanburg Herald-Journal
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
Spartanburg Herald-Journal / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
The Hendersonville Times-News
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
The Hendersonville Times-News / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
The Lexington Dispatch
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
The Lexington Dispatch / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
13d
Salon.com
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn’t get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
Salon.com / Posted 13 days ago
which he said is effective, consistent and doesn’t get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital’s study was born. Last month,... Read more
15 related stories
13d
Island Packet
Medical pot activists fear epilepsy drug could undercut themwhich he said is effective, consistent and doesn't get users high. About two y
Medical pot activists fear epilepsy drug could undercut them
Island Packet / Posted 13 days ago
which he said is effective, consistent and doesn't get users high. About two years ago, Patel persuaded London-based GW Pharmaceuticals to give him enough of the medicine for a single patient, and his hospital's study was born. Last month,... Read more
15 related stories
22d
San Antonio Express-News
These States Could Approve Marijuana Use in 2016plan also gives local communities the option to say "no" if they don't want dis
These States Could Approve Marijuana Use in 2016
San Antonio Express-News / Posted 22 days ago
plan also gives local communities the option to say "no" if they don't want dispensaries operating in their towns. SOURCE: GW PHARMACEUTICALS After a well-funded anti-pot campaign financed by billionaire casino mogul Sheldon Adelson derailed... Read more
25d
San Antonio Express-News
Why This Marijuana Stock Sky-Rocketed 79% in MarchIMAGE SOURCE: GW PHARMACEUTICALS What: Following news that its marijuana deriv
Why This Marijuana Stock Sky-Rocketed 79% in March
San Antonio Express-News / Posted 25 days ago
IMAGE SOURCE: GW PHARMACEUTICALS What: Following news that its marijuana derived medicine reduced the number of seizures in patients with a rare form of epilepsy, shares of GW Pharmaceuticals plc soared 79.5% last month, according to data from S&P... Read more
27d
Chicago Tribune
Marijuana extract reduced seizures in kids with epilepsy: Lurie studycomponent that gets users high. The study at Lurie was part of a nationwide cl
Marijuana extract reduced seizures in kids with epilepsy: Lurie study
Chicago Tribune / Posted 27 days ago
component that gets users high. The study at Lurie was part of a nationwide clinical trial conducted by the drug's maker, GW Pharmaceuticals. While a preliminary study also produced encouraging results, the company said this was the first trial of... Read more

People in this news